⌕
Organon · OGN · NYSE
Tenet 45 · Mixed
Compare
$13.900.00%At closeTenet 45 · Mixed
$13.900.00 (0.00%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD

Organon (OGN) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue fell 2.9% in FY25, net margin 3.0%, and free cash flow (~$538.0M) tracks net income. Earnings are cash, not paper.
The four lines that matter · FY21–FY25
Revenue ($M)▼2.9%
6,216.0
FY21→FY25CAGR −0.4%/yr
Net income ($M)▼78.4%
187.0
one-off year: see footnoteCAGR −39.0%/yr
Free cash flow ($M)▼29.6%
538.0
FY21→FY25CAGR −27.7%/yr
Diluted EPS▼78.4%
0.72
FY21→FY25CAGR −39.3%/yr
What the receipts whisper · what a headline number hides
Share count
+2.6%

254.2mn → 260.8mn diluted shares since FY21. Broadly flat, so EPS moves with net income rather than with the share count.

Capex
$162.0M

steady at 2.6% of revenue (−7.4% YoY).

Returns vs FCF
16%

$88.0M returned vs $538.0M of FCF in FY25. Buybacks + dividends covered by cash flow.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)6216.0Revenue−2903.0COGS3313.0Gross profit−372.0R&D−1721.0SG&A824.0Op income−637.0Tax & other187.0Net income

3¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.

Margin trend · direction beats level Gross Operating Net
705335180%sector median net margin ~3%FY21FY25

Over this window: gross 61.9% → 53.3%. Net margin 3.0% is below the sector median.

The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
6,099.06,216.06,403.06,263.06,174.06,304.0▼2.9%−0.4%
Cost of revenue
2,859.02,903.02,688.02,515.02,294.02,399.0▲8.0%+4.9%
Gross profit
3,240.03,313.03,715.03,748.03,880.03,905.0▼10.8%−4.0%
Research & development
358.0372.0550.0536.0578.0443.0▼32.4%−4.3%
Selling, general & admin
1,712.01,721.01,760.01,893.01,704.01,668.0▼2.2%+0.8%
Total operating expenses
2,409.02,489.02,341.02,491.02,310.02,114.0▲6.3%+4.2%
Operating incomefeeds ROC rank
831.0824.01,374.01,257.01,570.01,791.0▼40.0%−17.6%
Other income, net
−328.0−399.0−567.0−584.0−448.0−262.0——
Pretax income
503.0425.0807.0673.01,122.01,529.0▼47.3%−27.4%
Income tax
290.0238.0−57.0−350.0205.0178.0—+7.5%
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings
213.0187.0864.01,023.0917.01,351.0▼78.4%−39.0%
Per share
Diluted EPSbuyback-sensitive
0.770.723.333.993.595.31▼78.4%−39.3%
Diluted shares (mn)
272.38260.76259.15256.27255.17254.19▲0.6%+0.6%
Margins
Gross margin32nd pct in Healthcare
53.1%53.3%58.0%59.8%62.8%61.9%▼4.7pp−8.6pp
Operating margin
13.6%13.3%21.5%20.1%25.4%28.4%▼8.2pp−15.2pp
Net margin50th pct in Healthcare
3.5%3.0%13.5%16.3%14.9%21.4%▼10.5pp−18.4pp
† TTM = trailing four quarters through 2026-09-30.FY23 effective tax rate was −52% vs a 12% norm for this window, likely a one-time item; see the filing.FY24 effective tax rate was −7% vs a 12% norm for this window, likely a one-time item; see the filing.
FY19 – FY20 · 2 more years
Unlock the full history →
2 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-24 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Organon's revenue last fiscal year?

Organon reported revenue of $6,216.0M in fiscal 2025, down 2.9% from fiscal 2024.

What was Organon's net income?

Organon reported net income of $187.0M in fiscal 2025, a net margin of 3.0%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.